Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Safety and tolerability of dexamethasone combined with standard-of-care Ribavirin for the treatment of Lassa fever: An open-label randomized controlled phase II clinical trial

2025Journal of Interventional Epidemiology and Public HealthJournalOpen access

10.37432/jieph-confpro5-00022 Full text0 citations

Authors

6 authors across 5 institutions in 2 countries.

Sylvanus A OkogbeninFirst author
- Irrua Specialist Teaching Hospital (NG)
as printed: Sylvanus Okogbenin
Cyril Erameh
- Irrua Specialist Teaching Hospital (NG)
Osahogie Edeawe
- Irrua Specialist Teaching Hospital (NG)
Stephan Günther
Michael Ramharter
Mirjam GrogerSenior authorCorresponding

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Viral Infections and Outbreaks Researchlevel 3 · 1.00
Disaster Response and Managementlevel 3 · 0.99
Retinal and Optic Conditionslevel 3 · 0.92

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2025 · Journal of Interventional Epidemiology and Public Health · 0 citations
https://openalex.org/W4415302854

Safety and tolerability of dexamethasone combined with standard-of-care Ribavirin for the treatment of Lassa fever: An open-label randomized controlled phase II clinical trial · Sankore